Dan L. Duncan Cancer Center at Baylor College of Medicine

Houston, Texas 77030

1 studies enrolling now · 15 studies all time

What they study most

Anal Cancer, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Carcinoma of Unknown Primary, Leukemia, Lymphoma, Nonneoplastic Condition, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Cancer, Penile Cancer

Studies at this site

• Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma — Recruiting now
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors — Completed
• Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males — Completed
• Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer — Completed
• Letrozole in Preventing Breast Cancer in Postmenopausal Women — Completed
• Health-Related Quality of Life in Gay Men With Localized Prostate Cancer — Completed
• Symptom Management in African-American Men With Localized Prostate Cancer — Withdrawn before enrolling
• Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer — Completed
• Bexarotene in Preventing Breast Cancer in Women at Genetic Risk — Completed
• Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma — Completed
• Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer — Completed
• MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer — Stopped early
• Health-Related Quality of Life in Patients With Bladder Cancer — Completed
• Quality of Life and Symptom Management in Patients With Bladder Cancer — Completed
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors — Stopped early